The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...

Whereas previous research showed that ownership labeling among underrepresented groups mostly leads to “ingroup” support (i.e ...

That number dropped to fewer than 5 percent by 2008.) The FDA smacked a black box label on estrogen products used in hormone therapy a year later, where it has remained to this day.